Tobrex and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is reported as a side effect among people who take Tobrex (tobramycin), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Tamoxifen Citrate, and have Sleep apnea syndrome.

The phase IV clinical study analyzes which people have Memory loss when taking Tobrex. It is created by eHealthMe based on reports of 752 people who have side effects when taking Tobrex from the FDA, and is updated regularly.

What is Tobrex?

Tobrex has active ingredients of tobramycin. eHealthMe is studying from 762 Tobrex users. Check the latest studies of Tobrex.

What is Memory loss?

Memory loss is found to be associated with 2,726 drugs and 4,378 conditions by eHealthMe. Check the latest studies of Memory loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

752 people reported to have side effects when taking Tobrex.
Among them, 35 people (4.65%) have Memory loss.

Among these 35 people:

How long have people been on Tobrex when they have Memory loss? *

What is the gender of people who have Memory loss when taking Tobrex? *

female: 97.14 %
male: 2.86 %

What is the age of people who have Memory loss when taking Tobrex? *

What are other drugs people take besides Tobrex? *

What are other side effects people have besides Memory loss? *

Pain: 32 people, 91.43%
Diarrhea: 32 people, 91.43%
Neuropathy Peripheral (surface nerve damage): 31 people, 88.57%
Hallucinations (sensations that appear real but are created by your mind): 31 people, 88.57%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 31 people, 88.57%
Swelling Face: 31 people, 88.57%
Infection: 31 people, 88.57%
Bone Disorder: 31 people, 88.57%
Fatigue (feeling of tiredness): 30 people, 85.71%
Sinusitis (inflammation of sinus): 28 people, 80.00%

What are the existing conditions these people have? *

Sleep Apnea Syndrome: 23 people, 65.71%
Bone Density Decreased: 15 people, 42.86%
Metastases To Bone (cancer spreads to bone): 6 people, 17.14%
Bone Loss: 4 people, 11.43%
Pain: 1 person, 2.86%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 2.86%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 2.86%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 2.86%
Herpes Zoster: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Tobrex and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tobrex:

Tobrex (762 reports)

Memory loss treatments and more:

Memory loss (244,445 reports)

Browse all side effects of Tobrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Memory loss:

Memory loss (2,726 drugs)

Browse all the conditions that are associated with Memory loss:

Memory loss (4,378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin (the active ingredients of Tobrex) and Tobrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.